(Q45174290)

10 December 2017

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial (English)

1 reference

10 December 2017

1 reference

R D Chapurlat

1

1 reference

10 December 2017

L Palermo

series ordinal

2

1 reference

10 December 2017

P Ramsay

series ordinal

3

1 reference

10 December 2017

S R Cummings

series ordinal

4

1 reference

10 December 2017

language of work or name

English

0 references

publication date

3 December 2004

1 reference

Osteoporosis International

10 December 2017

1 reference

10 December 2017

16

1 reference

10 December 2017

7

1 reference

10 December 2017

842-848

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-004-1770-7

10 December 2017

0 references

cites work

Design of the Fracture Intervention Trial

1 reference

12 December 2020

Trabecular bone architecture in the pathogenesis and prevention of fracture

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Vertebral structure and strength in vivo and in vitro

1 reference

12 December 2020

How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?

1 reference

12 December 2020

Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Architecture and vertebral fracture

1 reference

12 December 2020

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Vertebral fracture assessment using a semiquantitative technique.

1 reference

12 December 2020

Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures

1 reference

12 December 2020

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

1 reference

12 December 2020

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

10.1007/S00198-004-1770-7

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference